Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
Endocr J ; 68(7): 849-856, 2021 Jul 28.
Article in English | MEDLINE | ID: covidwho-1150573

ABSTRACT

At the current time of rising demand for hospital beds, it is important to triage COVID-19 patients according to the treatment needed during hospitalization. The need for oxygen therapy is an important factor determining hospital admission of these patients. Our retrospective study was designed to identify risk factors associated with the progression to oxygen requirement in COVID-19 patients. A total of 133 patients with laboratory-confirmed COVID-19 were admitted to our hospital from February 22, 2020, to August 23. After excluding asymptomatic, non-Japanese, pediatric, pregnant patients and also those who needed oxygen immediately at admission, data of the remaining 84 patients were analyzed. The patients were separated into those who required oxygen after admission and those who did not, and their characteristics were compared. Age, body mass index (BMI), lymphocyte count, C-reactive protein (CRP), lactate dehydrogenase, estimated glomerular filtration rate, glucose intolerance, hypertension, and dyslipidemia were significantly different between the two groups. Multivariate analysis identified four significant and independent risk factors of oxygen requirement, including advanced age, obesity, glucose intolerance and lymphocytopenia. Dividing the patients into subgroups according to the number of these risk factors found in each patient indicated that the need for oxygen increased with higher number of these risk factors in the same individual. Our results suggest that the presence of higher number of these risk factors in COVID-19 patients is associated with future oxygen requirement and that this index can be potentially useful in triaging COVID-19 patients staying home in the context of need for hospitalization.


Subject(s)
COVID-19/complications , Glucose Intolerance/complications , Lymphopenia/complications , Obesity/complications , Oxygen/therapeutic use , Respiratory Distress Syndrome/etiology , Adult , Age Factors , Aged , Aged, 80 and over , Aging/physiology , Body Mass Index , COVID-19/epidemiology , COVID-19/pathology , COVID-19/therapy , Cohort Studies , Female , Glucose Intolerance/epidemiology , Hospitalization/statistics & numerical data , Humans , Japan/epidemiology , Lymphopenia/epidemiology , Male , Middle Aged , Obesity/epidemiology , Respiration, Artificial/statistics & numerical data , Respiratory Distress Syndrome/epidemiology , Respiratory Distress Syndrome/therapy , Respiratory Distress Syndrome/virology , Respiratory Insufficiency/epidemiology , Respiratory Insufficiency/etiology , Respiratory Insufficiency/therapy , Retrospective Studies , Risk Factors , SARS-CoV-2/physiology , Severity of Illness Index , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL